A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
UCN-01联合伊立替康治疗耐药性实体瘤恶性肿瘤患者的I期研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-010-1410-1
Fracasso, Paula M; Williams, Kerry J; Chen, Ronald C; Picus, Joel; Ma, Cynthia X; Ellis, Matthew J; Tan, Benjamin R; Pluard, Timothy J; Adkins, Douglas R; Naughton, Michael J; Rader, Janet S; Arquette, Matthew A; Fleshman, James W; Creekmore, Allison N; Goodner, Sherry A; Wright, Lisa P; Guo, Zhanfang; Ryan, Christine E; Tao, Yu; Soares, Eliane M; Cai, Shi-Rong; Lin, Li; Dancey, Janet; Rudek, Michelle A; McLeod, Howard L; Piwnica-Worms, Helen
